查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088674

單細胞分析市場：按產品類型、技術、工作流程階段、細胞類型、應用和最終用戶分類的全球市場預測，2026-2032 年

Single Cell Analysis Market by Product Type, Technology, Workflow Stage, Cell Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，單細胞分析市場規模將達到 123.2 億美元，複合年成長率為 14.86%。

主要市場統計數據
基準年 2025 46.7億美元
預計年份：2026年 53.4億美元
預測年份 2032 123.2億美元
複合年成長率 (%) 14.86%

單細胞分析透過在單一細胞層級測量基因組學、轉錄組學、蛋白質組學、表觀基因和功能突變，而非依賴平均化的組織訊號，正在重新定義生命科學研究。這種能力在腫瘤學、免疫學、神經病學、幹細胞研究、感染疾病以及細胞和基因治療等領域尤其重要，因為在這些領域，罕見的細胞狀態和異質性微環境可能決定疾病的進展和治療反應。

該市場由既定的需求因素驅動，例如世界衛生組織全球癌症觀察站報告的癌症負擔日益加重、單細胞RNA定序和流式細胞技術在轉化研究中的日益普及、ClinicalTrials.gov追蹤的生技藥品和細胞療法研發管線的成長，以及來自美國國立衛生研究院（NIH）、英國公共基金委員會、英國研究與創新基金開發機構（日本科學機構）。隨著單細胞定序、空間生物學、微流體、高內涵成像和生物資訊學的融合，產業相關人員正從僅用於研究的工作流程轉向與臨床和製藥領域更相關的標準化、擴充性平台。

單細胞分析領域的變革性變化

單細胞分析領域正從以發現為導向的實驗轉向整合的、可重複的工作流程，將樣品製備、細胞分離、樣品製備、定序、成像和計算分析等環節連接起來。研究機構對能夠維持細胞活性、減少批次效應、支持多重分析並產生符合監管標準、適用於轉化研究的數據的平台的需求日益成長。

人工智慧在單細胞分析中的累積影響

人工智慧 (AI) 正在對單細胞分析的整個價值鏈產生累積影響。在上游工作流程中，AI 驅動的影像分析支持細胞分割、活力評估、形態分類和品管。在下游分析中，機器學習被叢集、細胞類型註釋、軌跡估計、批次校正、資料補全以及轉錄組、蛋白質組、表觀基因組和空間資料集的整合。

主要區域洞察：亞太地區、北美地區、歐洲、拉丁美洲、中東和非洲

亞太地區正迅速發展，中國、日本、韓國、印度、澳洲和新加坡都在基因組學基礎設施、癌症研究、再生醫學和生物製造領域投入大量資金。中國大規模的定序生態系統、日本AMED支持的生物醫學計畫、韓國的精準醫療舉措以及澳洲強大的學術基因組學網路，都在推動單細胞定序、流式細胞技術和太空生物學等技術的應用。印度正透過生物技術園區的建設、臨床研究的拓展以及低成本服務模式，加速發展，但該地區高階設備的普及程度仍不均衡。

關鍵區域洞察：東協、海灣合作理事會、歐盟、金磚國家、七國集團、北約

隨著新加坡、泰國、馬來西亞、越南、印尼和菲律賓不斷拓展生物醫學研究、癌症計畫和感染疾病監測，東協正成為單細胞分析的關鍵成長走廊。新加坡憑藉其先進的基因組學基礎設施和轉化醫學投資脫穎而出，而大規模的東協市場則蘊藏著巨大的長期需求成長潛力，這主要得益於定序成本的下降和臨床研究能力的提升。

重點國家洞察：美國、中國、德國、印度、日本、巴西等主要市場

美國憑藉國立衛生研究院 (NIH) 資助的生物學研究、強大的創業投資支持、大型製藥企業的研發投入以及在定序、流式細胞技術和空間體學的雄厚基礎，引領著生物技術的商業化和應用。加拿大則透過基因組學聯盟、癌症研究、免疫學和幹細胞科學做出貢獻。墨西哥作為北美生命科學供應鏈的一部分，正在推動臨床研究的擴展和實驗室的現代化。巴西在癌症研究機構、感染疾病研究和公立大學的支持下，成為拉丁美洲最重要的市場。

為單細胞分析產業的領導者提供的實用建議

產業領導者應優先考慮端到端工作流程的可靠性。投資於自動化樣品製備、標準化試劑、完善的品管和可互通的軟體，可以降低變異性，使單細胞分析更適用於製藥和臨床研究環境。

調查方法

本執行摘要是基於對已核實的二手資料的系統性審查，包括 PubMed 收錄的同行評審文獻、公共資料集和儲存庫、ClinicalTrials.gov、NIH RePORTER、FDA 和 EMA 指南、歐盟委員會檢驗計畫、國家基因組舉措、世衛組織和 GLOBOCAN 癌症資料、經合組織和世界銀行資料簡報、二級資訊來源知名投資人的產品資料。

結論

單細胞分析正逐漸成為精準醫學、藥物研發、免疫療法、再生醫學和系統生物學等領域的基礎技術。該領域正從孤立的單細胞RNA定序實驗發展為整合多體學和空間工作流程，從而闡明單一細胞在複雜組織中的行為。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 單細胞分析市場：依產品類型分類

  • 消耗品
    • 試劑盒和試劑
    • 實驗室設備和耗材
  • 裝置
    • 流式細胞儀
    • 影像系統
    • 質譜流式細胞儀
    • 序列器
  • 軟體
    • 數據分析軟體
    • 資料管理軟體

第8章 單細胞分析市場：依技術分類

  • 單細胞基因體學
    • 單細胞DNA定序
    • 單細胞拷貝數變異分析
  • 單細胞轉錄組學
  • 單細胞表觀基因
    • ScATAC-Seq
    • ScDNA-Seq
    • ScRNA-Seq
  • 單細胞蛋白質體學
  • 單細胞代謝體學

第9章 單細胞分析市場：依工作流程階段分類

  • 樣品製備
    • 組織權力下放
    • 細胞分離和計數
  • 單細胞分裂和條碼
    • 井基型
    • 基於液滴的
    • 微孔系統
  • 圖書館建設
  • 定序/檢測
  • 數據處理與解釋

第10章 單細胞分析市場：依細胞類型分類

  • 哺乳動物細胞
    • 人類細胞
    • 小鼠細胞
  • 非哺乳動物細胞

第11章 單細胞分析市場：依應用分類

  • 發育生物學
  • 免疫學
    • 自體免疫疾病
    • 感染疾病
  • 神經病學
    • 神經退化性疾病
    • 神經發育障礙
  • 腫瘤學
    • 血癌
    • 固體癌

第12章 單細胞分析市場：依最終用戶分類

  • 學術研究機構
  • 臨床和診斷檢查室
  • 受託研究機構
    • 臨床合約研究組織
    • 臨床前合約研究組織
  • 製藥和生物技術公司

第13章 單細胞分析市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 單細胞分析市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 單細胞分析市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Bruker Corporation
  • Cellarity, Inc. by Flagship Pioneering, Inc.
  • Corning Incorporated
  • Danaher Corporation
  • Deepcell, Inc.
  • Diasorin SpA
  • General Electric Company
  • Illumina, Inc.
  • LumaCyte, Inc.
  • MedGenome Inc.
  • Menarini Group
  • Merck KGaA
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies PLC
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN NV
  • Sartorius AG
  • Singleron Biotechnologies
  • Standard BioTools Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • Zafrens
Product Code: MRR-A339DAEFA8C2

The Single Cell Analysis Market is projected to grow by USD 12.32 billion at a CAGR of 14.86% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.67 billion
Estimated Year [2026] USD 5.34 billion
Forecast Year [2032] USD 12.32 billion
CAGR (%) 14.86%

Single cell analysis is redefining life science research by measuring genomic, transcriptomic, proteomic, epigenomic, and functional variation at the level of individual cells rather than relying on averaged bulk tissue signals. This capability is especially important in oncology, immunology, neurology, stem cell research, infectious disease, and cell and gene therapy, where rare cell states and heterogeneous microenvironments can determine disease progression and treatment response.

The market is supported by well-established demand drivers: the rising cancer burden reported by the WHO's Global Cancer Observatory, expanding use of single-cell RNA sequencing and flow cytometry in translational research, growth in biologics and cell therapy pipelines tracked through ClinicalTrials.gov, and continued public funding from agencies such as the NIH, European Commission, UK Research and Innovation, Japan AMED, and China's National Natural Science Foundation. As single-cell sequencing, spatial biology, microfluidics, high-content imaging, and bioinformatics converge, industry participants are shifting from research-use-only workflows toward standardized, scalable platforms with stronger clinical and pharmaceutical relevance.

Transformative Shifts in the Single Cell Analysis Landscape

The single cell analysis landscape is moving from discovery-focused experiments toward integrated, reproducible workflows that connect sample preparation, cell isolation, library preparation, sequencing, imaging, and computational interpretation. Laboratories increasingly require platforms that preserve cell viability, reduce batch effects, support multiplexing, and generate data compatible with regulatory-grade translational studies.

A major shift is the convergence of single-cell and spatial omics. Single-cell RNA sequencing identifies cell states, while spatial transcriptomics and multiplexed imaging reveal where those cells are located in tissue architecture. This combination is becoming central to tumor microenvironment research, immune profiling, developmental biology, and organ atlas initiatives such as the Human Cell Atlas and NIH Human Biomolecular Atlas Program.

Commercial differentiation is also changing. Instrument vendors, reagent suppliers, sequencing providers, software developers, and contract research organizations are competing on workflow completeness, sample throughput, sensitivity, data integration, and cloud-enabled analytics. The winners are likely to be organizations that can reduce cost per cell, support multiomic readouts, improve automation, and deliver interpretable insights for pharmaceutical R&D and precision medicine.

Cumulative Impact of Artificial Intelligence on Single Cell Analysis

Artificial intelligence is becoming a cumulative force across the single cell analysis value chain. In upstream workflows, AI-assisted image analysis supports cell segmentation, viability assessment, morphology-based classification, and quality control. In downstream analysis, machine learning is used for clustering, cell-type annotation, trajectory inference, batch correction, data imputation, and integration of transcriptomic, proteomic, epigenomic, and spatial datasets.

The impact is particularly strong in oncology and immunology, where AI can help identify rare immune subsets, infer cell-cell communication, and detect resistant tumor cell populations that may be missed in bulk sequencing. Public repositories such as Gene Expression Omnibus, Single Cell Expression Atlas, and Human Cell Atlas datasets are also enabling model training and benchmarking, although data harmonization remains a critical challenge.

AI adoption must be paired with transparent validation. Industry leaders need explainable models, curated reference atlases, documented preprocessing pipelines, and governance for patient-derived genomic data. As regulatory agencies increase attention on AI-enabled diagnostics and software as a medical device, organizations that combine computational performance with auditability, privacy, and reproducibility will be better positioned for clinical translation.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

Asia-Pacific is expanding rapidly as China, Japan, South Korea, India, Australia, and Singapore invest in genomics infrastructure, cancer research, regenerative medicine, and biomanufacturing. China's large sequencing ecosystem, Japan's AMED-backed biomedical programs, South Korea's precision medicine initiatives, and Australia's strong academic genomics networks support adoption of single-cell sequencing, flow cytometry, and spatial biology. India is gaining momentum through biotechnology parks, clinical research growth, and lower-cost service models, although access to high-end instruments remains uneven.

North America remains a leading center for single cell analysis because of NIH funding, mature biotechnology clusters, large pharmaceutical R&D budgets, advanced academic medical centers, and early adoption of high-throughput sequencing and cell therapy development. The United States anchors the region through strong demand in oncology, immunology, neuroscience, and drug discovery, while Canada contributes through genomics networks, stem cell research, and public health-oriented precision medicine programs.

Europe benefits from Horizon Europe, national genomics strategies, biobank networks, and strong clinical research systems across Germany, France, the United Kingdom, Italy, Spain, the Nordics, and the Netherlands. The region's emphasis on data protection under GDPR shapes how single-cell datasets are stored, shared, and analyzed. Latin America, led by Brazil and Mexico, is adopting single-cell tools through academic research, infectious disease studies, oncology collaborations, and regional sequencing centers, but budget constraints and import dependence affect purchasing cycles.

The Middle East is increasing investment through precision medicine, population genomics, and specialty hospital networks in the Gulf, particularly in Saudi Arabia, the United Arab Emirates, and Qatar. Africa's opportunity is tied to infectious disease research, human genetic diversity studies, and public health genomics, with South Africa and emerging centers in East and West Africa playing important roles. Across both regions, partnerships with global instrument vendors, academic consortia, and cloud-based bioinformatics providers are essential for capacity building.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN is becoming an important growth corridor for single cell analysis as Singapore, Thailand, Malaysia, Vietnam, Indonesia, and the Philippines expand biomedical research, cancer programs, and infectious disease surveillance. Singapore stands out for advanced genomics infrastructure and translational medicine investment, while larger ASEAN markets offer long-term volume potential as sequencing costs decline and clinical research capacity improves.

The GCC is building demand through national health transformation programs, precision medicine initiatives, and investment in tertiary care systems. Saudi Arabia, the United Arab Emirates, Qatar, and other Gulf economies are prioritizing genomics, oncology, rare disease research, and digital health, creating opportunities for single-cell platforms linked to population health and advanced diagnostics.

The European Union supports single cell analysis through coordinated research funding, cross-border consortia, biobanking frameworks, and regulatory emphasis on data quality and patient privacy. BRICS economies bring scale and scientific diversity: China and India offer large research populations and expanding biotechnology ecosystems, Brazil supports regional life science research, Russia maintains capabilities in molecular biology, and South Africa contributes to genomics and infectious disease research.

G7 countries remain central to innovation because they combine major pharmaceutical companies, leading academic institutions, advanced healthcare systems, and high research intensity. NATO members overlap significantly with North American and European innovation hubs, and defense-linked biosurveillance, infectious disease preparedness, and biosecurity priorities can indirectly support advanced cellular analysis capabilities.

Key Country Insights: United States, China, Germany, India, Japan, Brazil, and Other Major Markets

The United States leads commercialization and research adoption through NIH-funded biology, strong venture-backed biotechnology, major pharmaceutical R&D, and a deep installed base for sequencing, flow cytometry, and spatial omics. Canada contributes through genomics consortia, cancer research, immunology, and stem cell science, while Mexico is expanding clinical research and laboratory modernization as part of North American life science supply chains. Brazil is the most prominent Latin American market, supported by cancer institutes, infectious disease research, and public universities.

In Europe, the United Kingdom maintains strength in genomics, biobanking, and translational medicine through national genomics infrastructure and leading universities. Germany combines pharmaceutical manufacturing, diagnostics expertise, and strong academic research, while France advances single-cell applications through national research organizations and hospital networks. Italy and Spain are active in oncology, immunology, and academic sequencing, while Russia retains molecular biology capabilities despite procurement and collaboration constraints shaped by geopolitics.

In Asia-Pacific, China is a major demand center due to large-scale sequencing capacity, government-supported biotechnology, cancer research, and domestic instrument and reagent development. India is growing through genomics services, pharmaceutical outsourcing, and academic adoption, although affordability and infrastructure gaps influence uptake. Japan emphasizes high-quality translational research, regenerative medicine, and aging-related disease studies, while South Korea is strong in precision oncology, immunology, and digital health integration. Australia supports adoption through advanced biomedical institutes, national genomics programs, and strong clinical research networks.

Actionable Recommendations for Single Cell Analysis Industry Leaders

Industry leaders should prioritize end-to-end workflow reliability. Investments in automated sample preparation, standardized reagents, robust quality control, and interoperable software can reduce variability and make single cell analysis more suitable for pharmaceutical and clinical research settings.

Organizations should strengthen AI and bioinformatics capabilities through validated pipelines, curated reference datasets, and explainable analytics. Partnerships with academic medical centers, cancer institutes, and biobanks can improve access to clinically annotated samples and accelerate biomarker discovery.

Commercial strategies should be region-specific. In mature markets, differentiation should focus on multiomics, spatial integration, compliance, and high-throughput productivity. In emerging markets, suppliers should emphasize training, flexible pricing, local service support, and cloud-based analysis to overcome infrastructure constraints.

Research Methodology

This executive summary is based on a structured review of verified secondary sources, including peer-reviewed literature indexed in PubMed, public datasets and repositories, ClinicalTrials.gov, NIH RePORTER, FDA and EMA guidance, European Commission research programs, national genomics initiatives, WHO and GLOBOCAN cancer data, OECD and World Bank indicators, annual reports, investor presentations, and product documentation from established life science technology providers.

The analysis applies triangulation across scientific publications, public funding trends, clinical trial activity, regulatory developments, and technology adoption patterns. Market interpretation excludes unsupported claims and avoids unverified revenue or growth figures where public evidence is insufficient. Regional, group, and country insights are derived from observable research capacity, healthcare infrastructure, biotechnology investment, and documented policy initiatives.

Conclusion

Single cell analysis is becoming a foundational technology for precision medicine, drug discovery, immunotherapy, regenerative medicine, and systems biology. The field is advancing beyond isolated single-cell RNA sequencing experiments toward integrated multiomic and spatial workflows that reveal how individual cells behave within complex tissues.

Artificial intelligence, automation, and cloud bioinformatics will accelerate adoption, but reproducibility, data governance, affordability, and clinical validation remain decisive barriers. Organizations that combine scientific rigor with scalable workflows, regional adaptation, and trusted analytics will be best positioned to create long-term value in the global single cell analysis market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Single Cell Analysis Market, by Product Type

  • 7.1. Consumables
    • 7.1.1. Kits And Reagents
    • 7.1.2. Labware And Consumables
  • 7.2. Instruments
    • 7.2.1. Flow Cytometers
    • 7.2.2. Imaging Systems
    • 7.2.3. Mass Cytometers
    • 7.2.4. Sequencers
  • 7.3. Software
    • 7.3.1. Data Analysis Software
    • 7.3.2. Data Management Software

8. Single Cell Analysis Market, by Technology

  • 8.1. Single Cell Genomics
    • 8.1.1. Single-cell DNA-seq
    • 8.1.2. Single-cell CNV Profiling
  • 8.2. Single Cell Transcriptomics
  • 8.3. Single Cell Epigenomics
    • 8.3.1. ScATAC-Seq
    • 8.3.2. ScDNA-Seq
    • 8.3.3. ScRNA-Seq
  • 8.4. Single Cell Proteomics
  • 8.5. Single Cell Metabolomics

9. Single Cell Analysis Market, by Workflow Stage

  • 9.1. Sample Preparation
    • 9.1.1. Tissue Dissociation
    • 9.1.2. Cell Isolation & Counting
  • 9.2. Single Cell Partitioning & Barcoding
    • 9.2.1. Well-based
    • 9.2.2. Droplet-based
    • 9.2.3. Microwell-based
  • 9.3. Library Construction
  • 9.4. Sequencing / Detection
  • 9.5. Data Processing & Interpretation

10. Single Cell Analysis Market, by Cell Type

  • 10.1. Mammalian Cells
    • 10.1.1. Human Cells
    • 10.1.2. Mouse Cells
  • 10.2. Non-mammalian Cells

11. Single Cell Analysis Market, by Application

  • 11.1. Developmental Biology
  • 11.2. Immunology
    • 11.2.1. Autoimmune Diseases
    • 11.2.2. Infectious Diseases
  • 11.3. Neurology
    • 11.3.1. Neurodegenerative
    • 11.3.2. Neurodevelopmental Disorders
  • 11.4. Oncology
    • 11.4.1. Hematological Cancers
    • 11.4.2. Solid Tumors

12. Single Cell Analysis Market, by End User

  • 12.1. Academic & Research Institutes
  • 12.2. Clinical & Diagnostic Laboratories
  • 12.3. Contract Research Organizations
    • 12.3.1. Clinical CROS
    • 12.3.2. Preclinical CROS
  • 12.4. Pharmaceutical & Biotechnology Companies

13. Single Cell Analysis Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Single Cell Analysis Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Single Cell Analysis Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. 10x Genomics, Inc.
  • 17.2. Agilent Technologies, Inc.
  • 17.3. Becton, Dickinson and Company
  • 17.4. BGI Genomics Co., Ltd.
  • 17.5. Bio-Rad Laboratories, Inc.
  • 17.6. bioMerieux SA
  • 17.7. Bruker Corporation
  • 17.8. Cellarity, Inc. by Flagship Pioneering, Inc.
  • 17.9. Corning Incorporated
  • 17.10. Danaher Corporation
  • 17.11. Deepcell, Inc.
  • 17.12. Diasorin S.p.A.
  • 17.13. General Electric Company
  • 17.14. Illumina, Inc.
  • 17.15. LumaCyte, Inc.
  • 17.16. MedGenome Inc.
  • 17.17. Menarini Group
  • 17.18. Merck KGaA
  • 17.19. Novogene Co., Ltd.
  • 17.20. Oxford Nanopore Technologies PLC
  • 17.21. PerkinElmer Inc.
  • 17.22. Promega Corporation
  • 17.23. QIAGEN N.V.
  • 17.24. Sartorius AG
  • 17.25. Singleron Biotechnologies
  • 17.26. Standard BioTools Inc.
  • 17.27. Takara Bio Inc.
  • 17.28. Thermo Fisher Scientific, Inc.
  • 17.29. Zafrens

LIST OF FIGURES

  • FIGURE 1. GLOBAL SINGLE CELL ANALYSIS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL SINGLE CELL ANALYSIS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL SINGLE CELL ANALYSIS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL SINGLE CELL ANALYSIS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL SINGLE CELL ANALYSIS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL SINGLE CELL ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY CELL TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY CELL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL KITS AND REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL KITS AND REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL KITS AND REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LABWARE AND CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LABWARE AND CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LABWARE AND CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FLOW CYTOMETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FLOW CYTOMETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FLOW CYTOMETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MASS CYTOMETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MASS CYTOMETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MASS CYTOMETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SEQUENCERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SEQUENCERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SEQUENCERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SINGLE CELL GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SINGLE CELL GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SINGLE CELL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SINGLE-CELL DNA-SEQ MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SINGLE-CELL DNA-SEQ MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SINGLE-CELL DNA-SEQ MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SINGLE-CELL CNV PROFILING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SINGLE-CELL CNV PROFILING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SINGLE-CELL CNV PROFILING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SINGLE CELL TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SINGLE CELL TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SINGLE CELL TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SINGLE CELL EPIGENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SINGLE CELL EPIGENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SINGLE CELL EPIGENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SCATAC-SEQ MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SCATAC-SEQ MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SCATAC-SEQ MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SCDNA-SEQ MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SCDNA-SEQ MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SCDNA-SEQ MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SCRNA-SEQ MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SCRNA-SEQ MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SCRNA-SEQ MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SINGLE CELL PROTEOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SINGLE CELL PROTEOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SINGLE CELL PROTEOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SINGLE CELL METABOLOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SINGLE CELL METABOLOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SINGLE CELL METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL TISSUE DISSOCIATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL TISSUE DISSOCIATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL TISSUE DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CELL ISOLATION & COUNTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CELL ISOLATION & COUNTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CELL ISOLATION & COUNTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SINGLE CELL PARTITIONING & BARCODING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SINGLE CELL PARTITIONING & BARCODING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SINGLE CELL PARTITIONING & BARCODING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL WELL-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL WELL-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL WELL-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DROPLET-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DROPLET-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DROPLET-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MICROWELL-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MICROWELL-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MICROWELL-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL LIBRARY CONSTRUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL LIBRARY CONSTRUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL LIBRARY CONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SEQUENCING / DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SEQUENCING / DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SEQUENCING / DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DATA PROCESSING & INTERPRETATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DATA PROCESSING & INTERPRETATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DATA PROCESSING & INTERPRETATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MAMMALIAN CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MAMMALIAN CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MAMMALIAN CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HUMAN CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HUMAN CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HUMAN CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MOUSE CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MOUSE CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MOUSE CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NON-MAMMALIAN CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NON-MAMMALIAN CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NON-MAMMALIAN CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL DEVELOPMENTAL BIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL DEVELOPMENTAL BIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL DEVELOPMENTAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL IMMUNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL IMMUNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL NEURODEGENERATIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL NEURODEGENERATIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEURODEGENERATIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL NEURODEVELOPMENTAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEURODEVELOPMENTAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL NEURODEVELOPMENTAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL HEMATOLOGICAL CANCERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL HEMATOLOGICAL CANCERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL HEMATOLOGICAL CANCERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL SOLID TUMORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL SOLID TUMORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL SOLID TUMORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL CLINICAL & DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL CLINICAL & DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL CLINICAL & DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL CLINICAL CROS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL CLINICAL CROS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL CLINICAL CROS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL PRECLINICAL CROS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL PRECLINICAL CROS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL PRECLINICAL CROS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL PARTITIONING & BARCODING, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL PARTITIONING & BARCODING, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL PARTITIONING & BARCODING, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL PARTITIONING & BARCODING, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE SINGLE CELL ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL PARTITIONING & BARCODING, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. MIDDLE EAST SINGLE CELL ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL PARTITIONING & BARCODING, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. AFRICA SINGLE CELL ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 276. GLOBAL SINGLE CELL ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 287. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL PARTITIONING & BARCODING, 2018-2032 (USD MILLION)
  • TABLE 288. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 290. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 293. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 295. ASEAN SINGLE CELL ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 296. GCC SINGLE CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 299. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 300. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 301. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 302. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 303. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 304. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 305. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 306. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL PARTITIONING & BARCODING, 2018-2032 (USD MILLION)
  • TABLE 307. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 309. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 310. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 311. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 312. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 313. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 314. GCC SINGLE CELL ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 316. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 318. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 320. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 322. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 324. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 325. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL PARTITIONING & BARCODING, 2018-2032 (USD MILLION)
  • TABLE 326. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 328. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 329. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 330. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 331. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 332. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 333. EUROPEAN UNION SINGLE CELL ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 334. BRICS SINGLE CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 335. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 336. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 337. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 338. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 339. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 340. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 341. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL EPIGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 342. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 343. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 344. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY SINGLE CELL PARTITIONING & BARCODING, 2018-2032 (USD MILLION)
  • TABLE 345. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 346. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 347. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 348. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 349. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 350. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 351. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 352. BRICS SINGLE CELL ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 353. G7 SINGLE CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 354. G7 SINGLE CELL ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 355. G7 SINGLE CELL ANALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 356. G7 SINGLE CELL ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 357. G7 SINGLE CELL ANALYSIS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 358. G7 SINGLE CELL ANAL